Trial
NCT02162979
Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Loma Linda University
Collaborators
—
Condition
Parkinson's Disease
Intervention
sildenafil
Why stopped
Not enough subjects.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-30